Plasma fibroblast growth factor-21 levels in patients with inborn errors of metabolism
Fibroblast growth factor-21 (FGF21) levels are elevated in patients with primary mitochondrial disorders but have not been studied in patients with inborn errors of metabolism (IEM) known to have secondary mitochondrial dysfunction. We measured plasma FGF21 by ELISA in patients with and without IEM....
Main Authors: | Brian Kirmse, Juan Cabrerra-Luque, Omar Ayyub, Kristina Cusmano, Kimberly Chapman, Marshall Summar |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-12-01
|
Series: | Molecular Genetics and Metabolism Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214426917300253 |
Similar Items
-
Inborn Errors of Metabolism
by: Erich Maul
Published: (2009-05-01) -
Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism
by: Josef Finsterer, et al.
Published: (2018-03-01) -
EPILEPSY IN INBORN ERRORS OF METABOLISM
by: E. D. Belousova
Published: (2016-06-01) -
Screening for Inborn Errors of Metabolism
by: F.A. Elshaari, et al.
Published: (2013-09-01) -
Carnitine Inborn Errors of Metabolism
by: Mohammed Almannai, et al.
Published: (2019-09-01)